Clinical Trials Browser

Interventional × Endostatins × 1 year × Clear all

NCT03086681 2025-07-29

ECWHCCFLACC

Phase 2 Completed

Uterine Cervical Neoplasms

NCT06617936 2025-07-15

Tislelizumab Combined With Recombinant Human Endostatin Combined With Chemotherapy for Unresectable Stage III Non-small Cell Lung Cancer.

Phase 2 Recruiting

Unresectable Non-small Cell Lung Cancer